Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer
Take Home Message Ex vivo three-dimensional microtumor testing shows promise in predicting chemotherapy response in patients with bladder cancer within clinical timelines, highlighting its potential to serve as a clinical biomarker to guide treatment decision-making.